EDGAR Filing Documents for 0001437749-24-026888

Form 8-K - Current report:

SEC Accession No. 0001437749-24-026888

Filing Date

2024-08-14

Accepted

2024-08-14 17:27:16

Documents

Period of Report

2024-08-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	nrxp20240813_8k.htm iXBRL	8-K	50060
2	EXHIBIT 3.1	ex_714611.htm	EX-3.1	4010
3	EXHIBIT 4.1	ex_713629.htm	EX-4.1	182255
4	EXHIBIT 4.2	ex_713630.htm	EX-4.2	108091
5	EXHIBIT 10.1	ex_713631.htm	EX-10.1	328040
6	EXHIBIT 10.2	ex_713632.htm	EX-10.2	173163
7	EXHIBIT 10.3	ex_713633.htm	EX-10.3	25572
8	EXHIBIT 10.4	ex_713634.htm	EX-10.4	152879
9	EXHIBIT 10.5	ex_713635.htm	EX-10.5	93902
10	EXHIBIT 10.6	ex_714090.htm	EX-10.6	56126
11	EXHIBIT 99.1	ex_714091.htm	EX-99.1	16949
16		nrxlogo.jpg	GRAPHIC	1946
	Complete submission text file	0001437749-24-026888.txt		1606644

Data Files

Seq	Description	Document	Type	Size
12	XBRL TAXONOMY EXTENSION SCHEMA	nxrp-20240812.xsd	EX-101.SCH	3871
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	nxrp-20240812_def.xml	EX-101.DEF	14176
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	nxrp-20240812_lab.xml	EX-101.LAB	18696
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	nxrp-20240812_pre.xml	EX-101.PRE	14263
27	EXTRACTED XBRL INSTANCE DOCUMENT	nrxp20240813_8k_htm.xml	XML	4941

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801

Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134

NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)